4 methods · Source-audited Jun 12, 2026Low confidence (34%)
The four valuation methods disagree significantly (14.7× spread). Treat this as a wide reference range only — not a reliable point estimate.
$13B
wide range · ~$7B – ~$61B
Implied per-share: $97.4 · vs last primary +162%
No verified public secondary-market signal available for Devoted Health. The estimate relies on last confirmed financing, peer multiples, sector momentum, and time decay.
Valuation basis:Last primary roundSource-audited Jun 12, 2026
Last primary round
$13B
Series E · 23mo ago
Secondary signal
—
No verified secondary signal
No verified public secondary signal is available. Hiive/Forge links are monitoring links only, not evidence of a current executable price.
Headcount
2,000
employees · LinkedIn+11%
LinkedIn count — directional proxy only. Historical figure sourced via Wayback Machine; treat ±15% as normal variance.
Revenue (est.)
$1.5B
annual run rate · est.
Complete company data
Every input we use, where we got it from, and how much we trust it.
Derived/estimated — SEC Form D filings, secondary price math, cap-table summaries[estimated — not authoritative]› notes
Public total fully-diluted share count: estimated from SEC Form D filings, secondary-market pricing math (implied valuation ÷ price per share), and leaked cap-table summaries. Considered the lowest-confidence input.
low
Implied share price (illustrative only)
~$97
$13B anchor × 1000 ÷ 350M shares[derived]› notes
Wide method spread — treat as illustrative mechanics only. The last primary round is a more reliable anchor for high-stakes decisions.
low
Primary equity type granted
ISO/NSO
Public reports of company equity practices
high
Financials
Annual revenue (est.)
$1,500M
Estimated — best available public estimates (Sacra, The Information, company ARR disclosures, press reports)[estimated — not independently verified]› notes
Annual revenue: best public estimates from Sacra, The Information, WSJ leaks, or company-stated ARR. Where official, we cite the source on the funding round.
medium
EV / Revenue (implied)
8.7x
Computed from valuation ÷ revenue[derived]
medium
Headcount
Employees (now)
2,000
LinkedIn — current company page count› notes
Headcount: LinkedIn 'Company' page employee count, taken now and approximately 12 months ago via the Wayback Machine. Treat as a directional proxy for revenue growth, not a hard number.
medium
Employees (12 months ago)
1,800
LinkedIn company page — historical snapshot via Wayback Machine[estimated — ±15% directional proxy]
medium
12-month headcount growth
+11%
Computed[derived]
medium
Methodology inputs
Sector ETF proxy
ARKG
Editorial choice — most representative public ETF› notes
Sector ETF: editorial choice of the most representative public-market proxy. Annual return: 3-year trailing average from Yahoo Finance, refreshed quarterly.
medium
ETF annual return (trailing 3-yr)
16%
Yahoo Finance · refreshed quarterly
medium
Funding history
Primary rounds reported in Bloomberg, WSJ, TechCrunch, Reuters, or SEC Form D filings (efts.sec.gov). Linked per round below.
Secondary market signals: bid/ask/trade indications from Hiive (hiive.com), Forge Global, Caplight Index, and tender prices reported in the press.
No active listings found
We monitor Hiive, Forge Global, and EquityZen for Devoted Health listings. As of July 2026, no verified secondary market activity has been recorded.
Secondary listings for private companies appear without announcement and typically close within days. When a listing appears, it often signals an upcoming tender offer or funding round.
Primary round history as valuation signal
In the absence of secondary market data, the funding history below is the primary valuation anchor. Method C (time-decay) uses this data to estimate current value.
Series E · 2024-08$13B
Series C · 2021-06$12.6B
Series B · 2020-01$1.8B
Get notified when a listing appears
Pro subscribers get notified within 2 hours when a secondary listing for Devoted Health is detected. Most employees first hear about tender offers days after the market already knows.
Public peer comparables: editorial selection of public companies with the closest business model. EV/Revenue and growth from public 10-Q filings and Bloomberg, refreshed quarterly.
Ticker
Company
EV / Revenue
Revenue growth
As of
AMWL
American Well Corporation
0.64x
+-18%
2026-07-10
DOCS
Doximity, Inc.
6.24x
+5%
2026-07-10
TDOC
Teladoc Health, Inc.
0.66x
+-3%
2026-07-10
VEEV
Veeva Systems Inc.
9.28x
+16%
2026-07-10
Confidence breakdown
How much we trust each of the four valuation methods for this specific company, and why.
Weighted average of the four methods. Above 60% is high, 35–60% medium, below 35% low.
Low
Worked example for an employee
Illustrative mechanics only — this shows how the equity model works, not a reliable value estimate.
Illustrative mechanics only
This example shows equity mechanics only. It is not a reliable estimate of current value because model support is weak (confidence 34%, spread 14.7×).
Show illustrative values (not a reliable estimate) ▸
Profile: a hypothetical employee who joined Devoted Health 24 months ago (2024-07-10) with 2,000 options, on the standard 4-year vesting schedule with a 1-year cliff.
Vesting
1,000 of 2,000
50% vested at month 24
Implied share price (mid)
$97
weighted average of 4 methods — low confidence
Gross vested value
$97,399
vested shares × implied price
Net value
$97,399
no strike, gross = net
Tax (rough)
$16,481
US federal only · AMT risk: medium
What if the next round is…
Up round +30%
$110,103
New round at +30% valuation, 15% new shares issued
Down round −30%
$56,816
New round at −30% valuation, 20% new shares (higher dilution in distress)
Secondary today
$82,789
Sale on the secondary market at the typical 15% discount to the mid estimate
These illustrative values use the same calculation engine as the live calculator, but the underlying model is low-confidence for Devoted Health. Use your own numbers as a starting point only. Try the calculator →
Transparent assumptions
What we assumed where exact data isn't available. If any of these don't match your situation, the numbers above will be off.
Fully-diluted share count
350M shares
We don't have authoritative cap-table access for private companies. The number above is reconstructed from SEC Form D filings, secondary-market price-vs-valuation math, and leaked share-class summaries. Actual fully-diluted count (including unvested option pool and SAFEs) may differ by 5–15%.
Common-stock waterfall
1.0× to common
We assume a clean common-stock outcome — i.e. preferred-share liquidation preferences and ratchets do not extract value before common. In a down-exit, this assumption can be very wrong: preferred stack can take 30–70% of proceeds.
Private-company illiquidity discount
25% off public peers
Applied to Method A (peer-multiple). Per-company because category leaders with deep secondary markets and a clear IPO path warrant a smaller discount than early-stage names. The literature range is 10–35%; for Devoted Health we use 25% based on secondary-market depth, valuation history, and proximity to liquidity.
Revenue growth assumption (Method C)
40% YoY
Compounded forward from the last primary date to today to estimate the company's value drift. Set per-company based on disclosed or reported ARR trajectory. Method C is further capped at 1.3× the most recent secondary trade (if any) to stop runaway extrapolation when revenue growth outpaces what the market is actually paying.
Sector ETF momentum (Method D)
ARKG @ 16%/year
Method D applies the trailing return of ARKG as a market-proxy adjustment to the primary valuation. Crude — meant as a tiebreaker when peer and secondary data conflict, not as a primary signal.
Outlier auto-downweight
Methods >50% from median get ½ weight
Robust-statistics safety net: any method whose output strays more than 50% from the median of the other three methods has its confidence weight halved when computing the blended mid-point. Prevents a single bad extrapolation from dragging the headline.
Recency decay for secondary trades
180-day half-life (e⁻ᵈ/¹⁸⁰)
A trade from 30 days ago counts ~5× more than one from 180 days ago. Tunable; some platforms use shorter half-lives.
Tax estimate
US federal only, single filer
Uses 2024 US federal brackets, ignoring state tax, NIIT, AMT credit recovery, and any other deductions. Treat as a directional sanity check, not a tax bill.
All data from public sources. Not investment, tax, or legal advice. Not affiliated with Devoted Health. Last refreshed manually — see methodology for our update cadence.